Saturday, June 12, 2010

AstraZeneca joins in sharing Alzheimer's data

Data on more than 4,000 Alzheimer's disease patients who have participated in 11 clinical trials have been compiled into a unified database meant to speed research into brain disease and help develop successful new treatments in an area that has stumped researchers.

Gaining access to such a vast pool of data should give researchers more information about the natural progression of the disease, and how the disease acts differently in certain groups of people.

Marc Cantillon, director of the coalition, said the group has focused on neuro-degenerative diseases "basically because we've been so hopeless in bringing new treatments."

 blog it